Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma.

Kenji InoueJunji InoueShiho Kunimatsu-SanukiNorie NozakiKosuke ShimizuKyoko IshidaGoji Tomita

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

After administration of omidenepag isopropyl, IOP in patients with NTG was significantly decreased. However, adverse reactions occurred in 7.4% of patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
optic nerve
optical coherence tomography